A PD-L1 Negative Advanced Gastric Cancer Patient With a Long Response to PD-1 Blockade After Failure of Systematic Treatment: A Case Report

BACKGROUND: It was widely accepted that programmed death-ligand 1 (PD-L1) positive, tumor mutational burden-high (TMB-H) or microsatellite instability-high (MSI-H) tumor are prone to have better treatment response to immune checkpoint blockade. The value of immune checkpoint blockade in PD-L1 negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangyuan, Zhang, Jieying, Zhao, Lei, Zhai, Menglan, Zhang, Tao, Yu, Dandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688253/
https://www.ncbi.nlm.nih.gov/pubmed/34950137
http://dx.doi.org/10.3389/fimmu.2021.759250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688253/
https://www.ncbi.nlm.nih.gov/pubmed/34950137
http://dx.doi.org/10.3389/fimmu.2021.759250

Ejemplares similares